FTXH

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change -0.35
Percentage change -1.32	%

Category	US Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	U.S.	Return% 1Y	0.15%	Total Holdings	50	Perf Week	0.57%
Sponsor	First Trust	ETF Type		Tags	equity	Return% 3Y	1.32%	AUM	14.75M	Perf Month	0.63%
Fund Family		Bond Type		Tags	pharmaceutical	Return% 5Y	4.44%	NAV/sh		Perf Quarter	6.51%
Index	Nasdaq US Smart Pharmaceuticals Index	Average Maturity		Tags	growth	Return% 10Y		52W High	29.72 -10.98%	Perf Half Y	-2.89%
Index Weighting		Commodity Type		Tags	value	Return% SI		52W Low	23.28 13.62%	Perf YTD	-1.90%
Active/Passive		Quant Type		Tags	volatility	Flows% 1M	-30.35%	Volatility	0.55% 0.63%	Perf Year	-3.20%
Dividend TTM	0.44 (1.66%)	ESG Type		Tags	-	Flows% 3M	-1.91%	ATR (14)	0.28	Perf 3Y	-1.89%
Dividend Ex-Date	Jun 26, 2025	Dividend Type		Sector/Theme		Flows% YTD	-1.87%	RSI (14)	58.22	Perf 5Y	15.48%
Dividend Gr. 3/5Y	17.10% 23.33%	Structure Type		Region		Flows% 1Y		Beta	0.54	Perf 10Y	-
Expense	0.60%	Growth/Value		SMA20	1.77%	Flows% 3Y		Rel Volume	0.02	Prev Close	26.81
Inverse/Leveraged		Market Cap		SMA50	3.17%	Flows% 5Y		Avg Volume	15.31K	Price	26.46
IPO	Sep 22, 2016	Option/Short	Yes / No	SMA200	-2.22%	Trades		Volume	268	Change	-1.32%

May-12-25 10:30AM	Pharma ETFs in Focus on Trump's Drug Price Overhaul (Zacks)
May-08-25 11:50AM	A Look at Pharma ETFs After Strong Q1 Earnings (Zacks)
May-02-25 03:25AM	Aim To Keep Risk Modest And Quality High (Seeking Alpha)
Apr-30-25 04:35AM	3 Ways To Avoid The Eye Of The Equity Market Storm (Seeking Alpha)
Apr-23-25 05:45AM	Rewiring Global Trade For Resilience And Growth (Seeking Alpha)
01:40PM	Loading…
Apr-18-25 01:40PM	Institutional, Retail Investors Shed $27B In U.S. Stocks In Early April Sell-Off (Seeking Alpha)
Apr-16-25 10:00AM	ETFs in Focus Post JNJ's Q1 Earnings Beat, Dividend Hike (Zacks)
Apr-04-25 08:30AM	How Will New Tariffs Impact Your Investment Portfolio In 2025? (Seeking Alpha) -5.98%
Apr-02-25 07:00AM	The Great Transformation: Riding The Wave Of Change (Seeking Alpha)
Apr-01-25 05:40AM	U.S. Consumers To Be Hit Hardest By Pharmaceutical Tariffs (Seeking Alpha)
Mar-28-25 06:05AM	Volatility Brings Changes To Market Leadership (Seeking Alpha)
Mar-20-25 04:32PM	How ESG Policies Can Keep The Healthcare Sector Fighting Fit (SeekingAlpha)
Nov-11-20 08:00AM	Ways To Make Money From Pfizer's Miracle Vaccine (Investor's Business Daily)
Feb-07-20 11:05AM	Pharma ETFs Gain on Healthy Q4 Earnings (Zacks)
Nov-06-19 11:00AM	Pharma ETFs Set to Benefit Post Strong Q3 Earnings (Zacks)
05:27PM	Loading…
Sep-24-19 05:27PM	First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds (Business Wire)
Aug-07-19 10:59AM	Pharma Q2 Earnings Growth Highest: Time to Buy ETFs? (Zacks)
May-09-19 10:05AM	Pharma ETFs Down Despite Solid Q1 Results (Zacks)
Mar-01-19 08:00AM	Why These Pharma ETFs Rallied on Thursday (Zacks)
Feb-28-19 04:43PM	Pharmaceutical ETFs Break Out on Horizon Pharmas Positive Drug Results (ETF Trends)
Feb-07-19 11:15AM	A Look at Pharma ETFs Post Q4 Results (Zacks)
Jan-23-19 02:04PM	Healthcare ETFs Slip After Abbot Labs Revenue Miss, Weak Outlook (ETF Trends)
Oct-24-18 11:59AM	ETF Strategies for the Midterm Elections (Zacks)
Oct-12-18 06:00AM	Top 5 Pharmaceutical ETFs for 2018 (Investopedia)
Jan-26-18 09:02AM	Pfizers 4Q17 Estimates: Products with Lower Sales (Market Realist)
Jan-12-18 07:31AM	Wall Street Recommendations for Mylan in January 2018 (Market Realist)
Jan-01-18 07:33AM	Eli Lillys New Products Portfolio in 3Q17 (Market Realist)
Sep-12-17 10:36AM	Behind Mercks Animal Health Segment Performance in 2Q17 (Market Realist)
Sep-04-17 09:06AM	What to Expect from Pfizers Biosimilars Business (Market Realist)
Sep-01-17 07:38AM	Performance of Eli Lillys Business Segments in 2Q17 (Market Realist)
09:07AM	Loading…
Aug-30-17 09:07AM	Major Developments for Johnson & Johnson in 2Q17 (Market Realist)
Aug-11-17 03:59PM	Pfizers Valuation after 2Q17 Earnings (Market Realist)
May-05-17 09:59AM	Trump Wins Healthcare Vote: ETFs to Watch (Zacks)
Mar-22-17 05:25PM	First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds (Business Wire)
Dec-09-16 09:36AM	Johnson & Johnsons Revenue Trend in 3Q16 (Market Realist)
Oct-25-16 03:04PM	Bristol-Myers Squibbs 3Q16 Estimates: Oncology Segment (Market Realist)
Oct-20-16 08:07AM	The Nasdaq Stock Market® Captures 35 Percent of U.S. ETP Listings and Switches in the Third Quarter of 2016 (GlobeNewswire)
Oct-14-16 12:04PM	Good News: Johnson & Johnsons 3Q16 Revenues Expected to Rise (Market Realist)
Sep-28-16 09:00AM	This Weeks ETF Launches: First Trust Tries Its Hands at Sectors (ETF Database)
Sep-27-16 09:00AM	This Weeks ETF Launches: First Trust Tries Its Hands at Sectors
Sep-22-16 01:55PM	7 First Trust Smart Sector ETFs to Diversify, Manage Risk (ETF Trends)
Sep-21-16 09:12AM	First Trust Launches Seven ETFs Based on Nasdaq US Smart Sector IndexesSM (Business Wire)

First Trust Nasdaq Pharmaceuticals ETF seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq US Smart Pharmaceuticals IndexTM. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depository receipts that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and weighted based upon their cumulative score on three investing factors: volatility, value and growth. It is non-diversified.

open in yahoo | open in marketwatch | open in google

First Trust Nasdaq Pharmaceuticals ETF

Upgrade your FINVIZ experience